JARISLOWSKY FRASER Ltd Has $229.51 Million Stake in UnitedHealth Group Incorporated $UNH

JARISLOWSKY FRASER Ltd lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 664,655 shares of the healthcare conglomerate’s stock after selling 4,839 shares during the quarter. UnitedHealth Group accounts for about 1.3% of JARISLOWSKY FRASER Ltd’s investment portfolio, making the stock its 28th biggest position. JARISLOWSKY FRASER Ltd owned about 0.07% of UnitedHealth Group worth $229,505,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the company. LFA Lugano Financial Advisors SA bought a new position in shares of UnitedHealth Group in the second quarter valued at approximately $25,000. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares during the period. Sagard Holdings Management Inc. bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $29,000. Islay Capital Management LLC bought a new stake in UnitedHealth Group in the second quarter valued at about $31,000. Finally, Riggs Asset Managment Co. Inc. raised its position in shares of UnitedHealth Group by 69.4% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 43 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $336.34 on Friday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The company has a market cap of $304.67 billion, a PE ratio of 17.55, a price-to-earnings-growth ratio of 1.99 and a beta of 0.42. The business’s 50 day moving average price is $330.58 and its two-hundred day moving average price is $319.72. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the previous year, the firm earned $7.15 EPS. The firm’s revenue was up 12.2% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were given a dividend of $2.21 per share. The ex-dividend date was Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target on the stock. KeyCorp lifted their price target on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Mizuho boosted their target price on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Royal Bank Of Canada raised their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Finally, Truist Financial raised their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Seventeen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $385.54.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.